Welcome to Medications.com

Low Dose ASA News

Eucreas®, A Single-tablet Combination Of Galvus® And Metformin ... - ABN Newswire (press release)

Eucreas is recommended for use twice-daily at a dose of either 50 mg vildagliptin/850 mg metformin or 50 mg vildagliptin/1000 mg metformin. ...

http://www.abnnewswire.net/press/... | Posted: Mon Feb 25 01:19:13 -0500 2008

One-stage Bilateral Total Joint Arthroplasty: A Prospective ... - Ortho SuperSite

Anticoagulation prophylaxis consisted of warfarin beginning the night of surgery and continuing at low dose (goal international normalized ration ...

http://www.orthosupersite.com/vie... | Posted: Thu Jan 31 09:41:26 -0500 2008

New Data Show Menveo(TM) To Be The First Quadrivalent ... - ABN Newswire (press release)

About the trial The Phase II randomized, open-label trial included 421 infants from the UK and Canada and evaluated multiple schedules including two 3-dose ...

http://www.abnnewswire.net/press/... | Posted: Tue Jan 08 17:29:09 -0500 2008

DJ HUGIN NEWS/New data show Menveo(TM) to be the first ... - cecu.de

About the trial The Phase II randomized, open-label trial included 421 infants from the UK and Canada and evaluated multiple schedules including two 3-dose ...

http://www.cecu.de/1404 M53d67ba6... | Posted: Wed Jan 09 05:34:55 -0500 2008

Phase I Safety and Tolerability Study - Ad-Hoc-News (Pressemitteilung)

The highest dose levelsexceed the expected maximum therapeutic dose planned to be used infurther clinical trials. For the treatment period and part of ...

http://www.ad-hoc-news.de/Corpora... | Posted: Mon Jan 07 09:37:57 -0500 2008

Phase I Safety And Tolerability Study With EVT 302 Successfully ... - ABN Newswire (press release)

EVT 302, a reversible and highly selective inhibitor of MAO-B in development for smoking cessation, was investigated in an ascending dose study with ...

http://www.abnnewswire.net/press/... | Posted: Mon Jan 07 09:26:54 -0500 2008

Phase I Safety and Tolerability Study - Ad-Hoc-News (Pressemitteilung)

all 18 news articles

Posted: Mon Jan 07 09:37:57 -0500 2008

Time for antioxidants v2.0 - NutraIngredients.com

Moreover, we need to link antioxidant content to an endpoint - for example, the dose of antioxidant needed to reduce a certain biological marker linked to ...

http://www.nutraingredients.com/n... | Posted: Mon Dec 17 07:05:52 -0500 2007

New data for Menveo vaccine show - Ad-Hoc-News (Pressemitteilung)

After a single dose of Menveo at age12 months, the percentages were > 93% for serogroups C and W-135 aswell as > 75% for serogroups A and Y. Of the subjects ...

http://www.ad-hoc-news.de/Corpora... | Posted: Thu Nov 15 01:19:07 -0500 2007

Oil Falls as Growth Outlook, OPEC Saps Confidence in $100 Oil - Bloomberg

statoilhydro ASA, BP Plc and conocophillips resumed production Nov. 9 after the storm abated. US equity prices dropped to a two-month low the same day as ...

http://www.bloomberg.com/apps/new... | Posted: Sun Nov 11 23:53:12 -0500 2007




Frequently Reported Side Effects of Low Dose ASA

© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea